Editorial
Published on 13 Nov 2024
Editorial: AI/ML in pharmacovigilance and pharmacoepidemiology
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1517365
- 1,714 views
- 1 citation
83 Publications
Volume 4 - 2024
Perspective
Published on 30 Oct 2024
External comparator studies and the joint application of the estimand and target trial emulation frameworks
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1409102
- 1,573 views
Opinion
Published on 18 Sep 2024
Achieving synchrony: bridging the gap between pharmaceutical companies and regulators on safety labeling updates
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1477516
- 1,874 views
- 1 citation
Original Research
Published on 17 Sep 2024
Demonstrating the principal mechanism of action of medical devices intended for vaginal use on reconstructed human vaginal epithelium: the case of two hyaluronic acid-containing devices
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1445519
- 1,611 views
- 1 citation
Original Research
Published on 16 Aug 2024
Exploring the scientific underpinnings of investigating safety signals: analytical insights in deciphering drug safety evidence
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1445998
- 2,219 views
- 2 citations
Original Research
Published on 12 Aug 2024
Cohort event monitoring of safety of COVID-19 vaccines: the Italian experience of the “ilmiovaccinoCOVID19 collaborating group”
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1363086
- 2,147 views
Original Research
Published on 19 Jul 2024
Measurement error and bias in real-world oncology endpoints when constructing external control arms
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1423493
- 3,920 views
- 1 citation
Original Research
Published on 27 Jun 2024
Assessing the performance of large language models in literature screening for pharmacovigilance: a comparative study
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1379260
- 3,251 views
- 5 citations
Original Research
Published on 13 May 2024
Progressive multifocal leukoencephalopathy reports in rheumatoid arthritis concerning different treatment patterns-an exploratory assessment using the food and drug administration adverse event reporting system
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1334468
- 1,597 views
- 1 citation
Methods
Published on 11 Apr 2024
Application of the target trial emulation framework to external comparator studies
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1380568
- 4,092 views
- 3 citations
Opinion
Published on 03 Apr 2024
Regulation 2017/745 on medical devices, two major innovations: 1) the physiological action of devices consisting of natural materials such as vegetal matrices; 2) the chemical-physical-mechanical action of devices made of “substances”, which as such are artificial derivatives
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1389406
- 1,664 views
- 1 citation
Original Research
Published on 20 Mar 2024
Machine learning analysis of patients’ perceptions towards generic medication in Greece: a survey-based study
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1363794
- 2,156 views
Review
Published on 18 Mar 2024
Artificial intelligence for optimizing benefits and minimizing risks of pharmacological therapies: challenges and opportunities
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1356405
- 5,040 views
- 5 citations
Editorial
Published on 06 Feb 2024
Editorial: Traditional and innovative approaches for signal detection
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1373689
- 1,348 views
Editorial
Published on 05 Feb 2024
Editorial: Treatment of comorbidities of asthma and its safety
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1366847
- 1,052 views
